SuperSonic Imagine, a French ultrasound company, announced that it has raised €28 million with €14 million invested by the FSI (French Investment Fund) alongside two new investors, Alto Invest and KLSC (Kuwait Life Sciences Company) and a substantial subscription from they company’s historical investors.
Edmond de Rothschild Investment Partners, Auriga Partners, Omnes Capital (formerly Crédit Agricole Private Equity), CDC Entreprises, NBGI Ventures, Wellington Partners, iXO Private Equity, and Mérieux Développement, along with Alto Invest and KLSC, are subscribing to €14 million.
SuperSonic Imagine will invest the funds to accelerate international sales and marketing of its Aixplorer ultrasound device, a product which originally targeted women’s health when it was launched in 2009, but which now covers all fields of general radiology, with regulatory approval in international markets.
Aixplorer’s competitive advantages include technologies such as: ShearWave Elastography and UltraFast Doppler. ShearWave Elastography is the only modality available on any ultrasound product that is able to detect tissue stiffness in a reproducible and quantifiable manner. UltraFast Doppler is unique in its ability to image blood flow up to ten times faster than conventional color Doppler. This not only provides more reliable diagnoses for the patient but it also significantly accelerates workflow for the practitioner.
